1. Home
  2. PCVX vs EHC Comparison

PCVX vs EHC Comparison

Compare PCVX & EHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PCVX
  • EHC
  • Stock Information
  • Founded
  • PCVX 2013
  • EHC 1983
  • Country
  • PCVX United States
  • EHC United States
  • Employees
  • PCVX N/A
  • EHC N/A
  • Industry
  • PCVX Biotechnology: Pharmaceutical Preparations
  • EHC Hospital/Nursing Management
  • Sector
  • PCVX Health Care
  • EHC Health Care
  • Exchange
  • PCVX Nasdaq
  • EHC Nasdaq
  • Market Cap
  • PCVX 6.0B
  • EHC 12.4B
  • IPO Year
  • PCVX 2020
  • EHC 1986
  • Fundamental
  • Price
  • PCVX $49.28
  • EHC $113.33
  • Analyst Decision
  • PCVX Strong Buy
  • EHC Strong Buy
  • Analyst Count
  • PCVX 7
  • EHC 8
  • Target Price
  • PCVX $101.67
  • EHC $141.88
  • AVG Volume (30 Days)
  • PCVX 1.5M
  • EHC 945.3K
  • Earning Date
  • PCVX 11-04-2025
  • EHC 10-29-2025
  • Dividend Yield
  • PCVX N/A
  • EHC 0.67%
  • EPS Growth
  • PCVX N/A
  • EHC 27.89
  • EPS
  • PCVX N/A
  • EHC 5.29
  • Revenue
  • PCVX N/A
  • EHC $5,795,600,000.00
  • Revenue This Year
  • PCVX N/A
  • EHC $11.54
  • Revenue Next Year
  • PCVX N/A
  • EHC $8.79
  • P/E Ratio
  • PCVX N/A
  • EHC $21.39
  • Revenue Growth
  • PCVX N/A
  • EHC 11.13
  • 52 Week Low
  • PCVX $27.66
  • EHC $87.85
  • 52 Week High
  • PCVX $94.76
  • EHC $127.99
  • Technical
  • Relative Strength Index (RSI)
  • PCVX 65.45
  • EHC 37.70
  • Support Level
  • PCVX $47.02
  • EHC $110.69
  • Resistance Level
  • PCVX $50.18
  • EHC $115.86
  • Average True Range (ATR)
  • PCVX 2.20
  • EHC 2.51
  • MACD
  • PCVX 0.21
  • EHC 0.02
  • Stochastic Oscillator
  • PCVX 89.68
  • EHC 28.18

About PCVX Vaxcyte Inc.

Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.

About EHC Encompass Health Corporation

Encompass Health Corp provides post-acute healthcare services in the United States through a network of inpatient rehabilitation hospitals. Inpatient rehabilitation contributes the majority of the firm's revenue and provides specialized rehabilitative treatment through a network of inpatient hospitals. These hospitals are concentrated in the eastern half of the United States and Texas.

Share on Social Networks: